News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Transgenomic, Inc. (TBIO) Announces Appointment of Mark P. Colonnese as Chief Financial Officer



9/13/2012 10:06:01 AM

OMAHA, Neb.--(BUSINESS WIRE)--Transgenomic, Inc. (OTCBB: TBIO) today announced the appointment of Mark P. Colonnese as Executive Vice President and Chief Financial Officer of the Company. In this role, Mr. Colonnese will lead the Company’s financial and capital markets strategy, as well as advise on business development and transactional activities.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES